insights_auto
Why is VEEV up 2.09%?
Dive Deeperchevron_right
VEEV:NYSE
Veeva Systems Inc
$301.94
arrow_upward
+2.09%(+6.19) 1D
Oct 13, 9:30:40 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VEEV...
Open
$300.00
High
$301.94
Low
$300.00
Mkt. cap
48.72B
Avg. vol.
1.49M
Volume
5.36K
P/E ratio
49.38
52-wk high
$302.17
52-wk low
$148.05
EPS
$6.11
Beta
0.93
Shares outstanding
161.91M
No. of employees
8K
Open
$300.00
High
$301.94
Low
$300.00
Mkt. cap
48.72B
Avg. vol.
1.49M
Volume
5.36K
P/E ratio
49.38
52-wk high
$302.17
52-wk low
$148.05
EPS
$6.11
Beta
0.93
Shares outstanding
161.91M
No. of employees
8K
News stories
From web sources and news partners
Investing.com Canada
·
2 hours ago
IQVIA selects Veeva clinical applications as enterprise standard By Investing.com
Stock Titan
·
2 hours ago
Four Veeva tools will be standard across IQVIA's clinical studies
Yahoo Finance
·
2 hours ago
IQVIA Selects Veeva Clinical Operations Applications
Investor's Business Daily
·
17 hours ago
How This IBD Stock Of The Day Is Taking On Salesforce
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com